Carregant...
Tipus de document
Treball de fi de grauData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/119663
Preparation of the enzymatic inhibitor UB-207
Títol de la revista
Autors
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Obesity has become a priority health issue for many governments and organisations such as the WHO, it has gained the status of epidemic and according to the past years trends, the forecasts are not hopeful. The research for anti-obesity drugs has grown in the past years as the percentage of obese people grows globally. A relatively new anti-cancer drug (C75) was tested as anti-cancer drug to rodents, and it was observed that the specimens were showing an anorexigenic behaviour. The molecule was interacting in the hypothalamus reducing the food intake. Since this side effect was discovered many have been the attempts to find derivatives and analogues of C75 focusing on its food intake modulator basal.
In this project, we have focused on the synthesis of C75 analogue called (±)-UB-207 that was first reported in 2012. The novelty of the present work consists in modifying the initial synthetic route in order to simplify the obtainment of the pure derivative
Descripció
Treballs Finals de Grau de Química, Facultat de Química, Universitat de Barcelona, Any: 2018, Tutor: Xavier Ariza Piquer
Matèries (anglès)
Citació
Col·leccions
Citació
GALINDO MUÑOZ, Alex. Preparation of the enzymatic inhibitor UB-207. [consulta: 20 de gener de 2026]. [Disponible a: https://hdl.handle.net/2445/119663]